Published in J Laryngol Otol on July 01, 1983
Second malignant tumours in head and neck cancer. BMJ (1991) 0.99
The EUROSCAN Study. EUROSCAN Steering Committee. Br J Cancer (1991) 0.82
Coexistence of metastatic lung cancer and pulmonary tuberculosis diagnosed in the same cavity. Int J Clin Oncol (2005) 0.79
Relationships of vitamins A and E and beta-carotene serum levels to head and neck cancer patients with and without second primary tumors. Eur Arch Otorhinolaryngol (1990) 0.78
Immunosuppressive retroviral-related factors in sera of patients with head and neck cancer. Eur Arch Otorhinolaryngol (1990) 0.78
Oral hybrid verrucous carcinoma: a clinical study. Indian J Surg Oncol (2014) 0.75
One patient--three head and neck primaries: nasopharyngeal, tongue and thyroid cancers. BMC Res Notes (2013) 0.75
Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx. Eur Arch Otorhinolaryngol (1991) 0.75
Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ (1991) 2.48
Severity of inflammation of tympanic membrane as predictor of clinical course of recurrent acute otitis media. BMJ (1993) 1.65
Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys (2001) 1.63
The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol (2000) 1.53
[Tumor growth during the waiting period for radiotherapy in patients with oropharyngeal carcinoma]. Ned Tijdschr Geneeskd (2003) 1.42
[Arguments favouring the pharmacotherapy of Bells' palsy]. Ned Tijdschr Geneeskd (2005) 1.40
Muscular changes in the guinea pig caused by chronic ascorbic acid deficiency. J Neurol Sci (1991) 1.37
Long-term quality of life of patients with head and neck cancer. Laryngoscope (2000) 1.32
Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer (2001) 1.30
Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18
Warthin's tumour and smoking. B-ENT (2005) 1.17
Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol (1990) 1.16
Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck (2000) 1.13
Psychological factors and patient delay in patients with head and neck cancer. Eur J Cancer (2004) 1.10
A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol (1999) 1.08
Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg (2000) 1.07
Phosphatidylethanolamine mediates insertion of the catalytic domain of leader peptidase in membranes. FEBS Lett (1998) 1.04
Differences in coping style and locus of control between older and younger patients with head and neck cancer. Clin Otolaryngol (2005) 1.02
Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol (1995) 1.00
F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer. Head Neck (2001) 1.00
A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck (1999) 1.00
Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol (2004) 0.99
Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol (2001) 0.99
Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Radiother Oncol (1998) 0.98
The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg (1991) 0.98
Landmarks for parotid gland surgery. J Laryngol Otol (2001) 0.98
Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol Allied Sci (2000) 0.98
Negative and positive influences of social support on depression in patients with head and neck cancer: a prospective study. Psychooncology (2000) 0.98
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998). Ann Oncol (2013) 0.98
T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results. Clin Otolaryngol Allied Sci (1992) 0.97
Ataxia and nystagmus induced by injection of local anesthetics in the Neck. Ann Neurol (1977) 0.96
A prospective longitudinal study on radiation-induced hearing loss. Am J Surg (1994) 0.94
Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies. J Neurol Sci (1989) 0.93
Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis (2007) 0.91
Prognostic factors for survival in patients with T3 laryngeal carcinoma. Am J Surg (1992) 0.91
The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur J Cancer B Oral Oncol (1994) 0.90
Prediction of depression 6 months to 3 years after treatment of head and neck cancer. Head Neck (2001) 0.89
Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer. Laryngoscope (1999) 0.89
Current indications for (adeno)tonsillectomy in children: a survey in The Netherlands. Int J Pediatr Otorhinolaryngol (2003) 0.89
Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck (2000) 0.88
Midsagittal pontomedullary brain stem section: effects on ocular adduction and nystagmus. Exp Neurol (1980) 0.87
Autopsy findings in patients with head and neck squamous cell cancer and their therapeutic relevance. Eur J Cancer B Oral Oncol (1996) 0.86
Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope (1998) 0.86
Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol (1998) 0.86
Tympanic membrane grafting with fascia, pericardium and vein. J Laryngol Otol (1982) 0.86
A review of clinical trials regarding treatment of acute otitis media. Clin Otolaryngol Allied Sci (1992) 0.86
Synovial sarcoma of the pharynx. Ear Nose Throat J (1984) 0.86
Medical care-seeking and health-risk behavior in patients with head and neck cancer: the role of health value, control beliefs and psychological distress. Health Educ Res (2005) 0.85
Postural and oculomotor signs in labyrinthine-defective subjects. Acta Otolaryngol Suppl (1984) 0.85
18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer (1999) 0.85
Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest (1999) 0.84
Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol (1999) 0.84
Treatment of localized non-Hodgkin's lymphomas of the head and neck. Cancer (1994) 0.84
Somatosensory compensation for loss of labyrinthine function. Acta Otolaryngol (1984) 0.84
Leishmania braziliensis presenting as a granulomatous lesion of the nasal septum mucosa. J Laryngol Otol (1997) 0.83
Proposal for a new nomenclature of some well-known clinical syndromes. Clin Neurol Neurosurg (1975) 0.83
Consequences of voice impairment in daily life for patients following radiotherapy for early glottic cancer: voice quality, vocal function, and vocal performance. Int J Radiat Oncol Biol Phys (1999) 0.82
The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med (1999) 0.82
Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta Neuropathol (1992) 0.82
Radiotherapy in epithelial tumors of the parotid gland: case presentation and literature review. Int J Radiat Oncol Biol Phys (1990) 0.81
Mammography in the follow-up after breast-conserving treatment in cancer of the breast: suitability for mammographic interpretation, validity and interobserver variation. Br J Radiol (1995) 0.81
Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Acta Oncol (2000) 0.81
Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int J Radiat Oncol Biol Phys (1991) 0.81
Mapping of resection margins of oral cancer for p53 overexpression and chromosome instability to detect residual (pre)malignant cells. J Pathol (2001) 0.81
Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life. Clin Otolaryngol Allied Sci (2003) 0.81
Preoperative determination of the location of parotid gland tumors by analysis of the position of the facial nerve. J Oral Maxillofac Surg (2001) 0.81
Uni- and multivariate analysis of eight indications for post-operative radiotherapy and their significance for local-regional cure in advanced head and neck cancer. J Laryngol Otol (1993) 0.80
Increased proliferative activity and p53 expression in normal glandular breast tissue after radiation therapy. J Pathol (1998) 0.80
Increased metallothionein in the liver and kidney of patients with amyotrophic lateral sclerosis. Arch Neurol (1992) 0.80
A gene expression profile for non-smoking and non-drinking patients with head and neck cancer. Oral Dis (2011) 0.80
The value of twice yearly bronchoscopy in the work-up and follow-up of patients with laryngeal cancer. Eur J Cancer (1993) 0.79
Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry (1995) 0.79
The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography. Oral Oncol (1999) 0.79
Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients. Exp Gerontol (1999) 0.79
Thallium-201 diethyldithiocarbamate: an alternative to iodine-123 N-isopropyl-p-iodoamphetamine. J Nucl Med (1985) 0.79
Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol (1995) 0.79
Single-dose radiotherapy (6 Gy): palliation in painful bone metastases. Radiother Oncol (1995) 0.79
FDG positron emission tomography in head and neck cancer: pitfall or pathology? Clin Nucl Med (1999) 0.79
Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital. Clin Otolaryngol Allied Sci (2004) 0.79
Optimal regimes for local IL-2 tumour therapy. Int J Cancer (1996) 0.78
Cervico-vestibular and visuo-vestibular interaction. Self-motion perception, nystagmus, and gaze shift. Acta Otolaryngol (1982) 0.78
Mechanisms of acquired resistance to methotrexate in a human squamous carcinoma cell line of the head and neck, exposed to different treatment schedules. Eur J Cancer (1991) 0.78
[Annual chest X-ray in patients after treatment for laryngeal or oral cancer: only a limited number of second primary lung cancers detected]. Ned Tijdschr Geneeskd (1999) 0.78
Metallothionein in amyotrophic lateral sclerosis. Biol Signals (1995) 0.78
Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett (1992) 0.78
Nystagmus, gaze shift, and self-motion perception during sinusoidal head and neck rotation. Ann N Y Acad Sci (1981) 0.78
Persistence of middle ear dysfunction after recurrent acute otitis media. Clin Otolaryngol Allied Sci (1994) 0.78
Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging. J Nucl Med (1998) 0.78
Efficacy of sinus irrigation versus sinus irrigation followed by functional endoscopic sinus surgery. Ann Otol Rhinol Laryngol (1997) 0.78
The antioxidant N-acetylcysteine does not delay disease onset and death in a transgenic mouse model of amyotrophic lateral sclerosis. Ann Neurol (1998) 0.78
Proliferative capacity in head and neck cancer. Head Neck (2001) 0.77
Management of depression in elderly general practice patients. Scand J Prim Health Care (1994) 0.77
Microbiology of chronic maxillary sinusitis in adults: isolated aerobic and anaerobic bacteria and their susceptibility to twenty antibiotics. Acta Otolaryngol (1995) 0.77
Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. Eur J Cancer B Oral Oncol (1996) 0.77
Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study regarding Tobacco and Alcohol Consumption. Patholog Res Int (2011) 0.77
Radioresistance and p53 status of T2 laryngeal carcinoma. Analysis by immunohistochemistry and denaturing gradient gel electrophoresis. Cancer (1996) 0.77
A unique case of intracranial metastasis from lung carcinoma. Clin Neurol Neurosurg (1993) 0.77
Carcinomas of the maxillary sinus: a retrospective study. Clin Otolaryngol Allied Sci (1985) 0.77